Please use this identifier to cite or link to this item: 192.168.6.56/handle/123456789/2146
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorOksuz, A.; Ozylmazen
dc.contributor.editorA. Dyshlovoy, Sergey-
dc.date.accessioned2018-09-18T09:33:25Z-
dc.date.available2018-09-18T09:33:25Z-
dc.date.issued2015-
dc.identifier.isbn978-3-03842-131-3-
dc.identifier.urihttp://10.6.20.12:80/handle/123456789/2146-
dc.descriptionIn Western countries, cancer is among the most frequent causes of death. Despite striking advances in cancer therapy, there is still an urgent need for new drugs in oncology. Current development favors so called “targeted agents” or drugs that target the immune system, i.e., therapeutic antibodies that enhance or facilitate an immune response against tumor cells (also referred to as “checkpoint inhibitors”)en
dc.languageenen
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.subjectcanceren_US
dc.titleMarine Compounds and Canceren_US
dc.typeBooken_US
Appears in Collections:Veterinary Medicine

Files in This Item:
File Description SizeFormat 
100,2015.pdf.pdf56.06 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.